Return to Trial Database

HCRN-LUN18-357

Induction durvalumab followed by chemoradiation and consolidation durvalumab (MEDI4736) for stage III non-small cell lung cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-LUN18-357 being conducted in.

No data was found